The World Health Organization has confirmed it has suspended the supply of Covaxin, produced by Hyderabad-based Bharat Biotech Ltd., through UN procurement agencies, and recommended to countries that received the vaccine to take actions as appropriate.
The WHO said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held from March 14–22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.
Company officials could not be reached immediately for a response.
Coronavirus cases globally passed 48.8 crore, with deaths crossing 61 lakh. More than 1,100 crore vaccine doses have been administered across the world.
